Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Forest’s Namenda Gets “Not Approvable” Letter For Mild Alzheimer’s Indication
Jul 25 2005
•
By
Kathleen Michael
More from Archive
More from Pink Sheet